EUCTR2011-001283-22-DE进行中（未招募）不适用
International follow-up study, after the investigational drug exposure in diabetic patients previously included in the REGULATE trial (benfluorex versus pioglitazone).
Institut de Recherches Internationales Servier (I.R.I.S.)0 个研究点目标入组 361 人开始时间: 2011年6月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 361
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •All the patients included in the REGULATE trial (CL3-00780-148) who were exposed to one of the study drugs
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 599
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 246
排除标准
- •Not applicable
研究者
相似试验
进行中（未招募）
不适用
Follow-up trial with no study drug prescription in diabetic patients previously included in the REGULATE trial.Type II diabetes The medical condition investigated in the REGULATE trial (CL3-00780-148) was type II diabetes. The applied CL3-00780-150 trial, REGULATE follow-up study, is thus performed in diabetic patients.MedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-001283-22-CZInstitut de Recherches Internationales Servier (I.R.I.S.)361
已完成
3 期
FOLLOW UP study for patients previously included in REGULATE study.CTRI/2011/11/002144Institut de recherches Internationales Servier845
招募中
2 期
Study to find effectiveness of dextrose injection in comparison of steroid injection in tennis elbow patients.CTRI/2024/05/066928SMS Medical College Jaipur
招募中
不适用
International multicenter observational study to determine the diagnostic sensitivity of plasma metanephrines and urinary catecholamines and metabolites compared to standard evaluation procedures in children with high risk neuroblastomaNeuroblastomaNL-OMON51513Centre Hospitalier Universitaire Vaudois-CHUV30
已完成
不适用
OTUS: LOng-Term follow-Up Study of triple-negative breast cancerCancerBreast cancerTriple-negative breast cancerISRCTN43423520niversity of Leeds (UK)500